help + privacy policy + contact us + links + home
 
About APhACareerse-CommunitiesMeetingsPublicationsJoin APhA

American 
Pharmacists 
Month

APhA CEO Blog

APhA 
Foundation



2010 International Pharmaceutical Federation PSWC and AAPS Annual 
Meeting

Print this page

Adverse event reporting mandated for supplements, OTCs
Manufacturers, packers, and distributors will have 15 days to notify FDA of serious harm associated with use of their products; requirements take effect next December.

Just before Congress went out of session last weekend, the Senate passed legislation that will require companies that make and distribute dietary supplements and OTC drugs to inform federal authorities about serious adverse events among users of their products. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546) would also require the manufacturer, packer, or distributor whose name appears on a product’s label to include its address or phone number on the label.

President Bush is expected to sign the legislation later this month, and it will become enforceable 1 year after it is signed.

Sen. Orrin Hatch (R-Utah), who introduced the bill in June, said, “This new legislation complements the 1994 supplement law [the Dietary Supplement Health and Education Act] I authored by providing federal authorities with an additional tool to identify when serious problems occur.”

When S. 3546 takes effect, supplement and OTC drug companies will have to notify FDA within 15 days of learning of patient harm resulting from one of their products. Companies will use MedWatch forms to make reports and will also have to submit follow-up reports on new medical information in individual cases. Product labels must be submitted with adverse event reports, and companies making the reports must keep copies of all filings for 6 years.

The law defines a serious adverse event as “death, a life-threatening experience, inpatient hospitalization, a persistent or significant disability or incapacity, or a congenital anomaly or birth defect” that occurs or must be prevented by a surgical or medical intervention also falls under the definition of serious adverse event.

The U.S. Department of Health and Human Services will issue more complete guidance by the end of August 2007. Failure to comply with the reporting and record-keeping requirements could result in prison sentences of up to a year and fines up to $1,000 for each offense.

APhA CEO and Executive Vice President John Gans, PharmD, welcomed the new law as an important step for protecting patients’ health. “APhA has encouraged additional oversight of dietary supplements for years,” he said. “Encouraging health care professionals, manufacturers, and consumers to report adverse health events associated with dietary supplements will help pharmacists help patients get the best from supplements and avoid potential problems.”

Rep. Chris Cannon, who is also a Republican from Utah, sponsored the companion bill to S. 3546 in the House. It is telling that the mandatory supplement adverse event reporting law was championed by lawmakers from Utah. The Beehive State is home to the largest number of dietary supplement makers in the United States, and in November 2003, the magazine Utah Business reported that 20 of the state’s largest 25 public companies made supplements.

S. 3546 drew strong support from the American Herbal Products Associations, the Center for Responsible Nutrition, and the Consumer Healthcare Products Association (CHPA). In a press statement, CHPA President L inda A. Suydam , DPA, s aid her organization “ looks forward to seeing mandatory adverse event reporting for all OTC medicines and nutritional supplements become a reality. In addition to bolstering public confidence, the establishment of a mandatory system also will benefit manufacturers by standardizing the scope and extent of reporting to FDA."


Web links

Related resources on www.pharmacist.com

Contact the writer: Ed Lamb, Pharmacy Today

Posted December 14, 2006, 4:30 pm EST